Biochemical and structural analysis of 14 mutant adsl enzyme complexes and correlation to phenotypic heterogeneity of adenylosuccinate lyase deficiency
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
20127976
DOI
10.1002/humu.21212
Knihovny.cz E-zdroje
- MeSH
- adenylsukcinátlyasa chemie nedostatek genetika MeSH
- elektroforéza v polyakrylamidovém gelu MeSH
- fenotyp MeSH
- genetická heterogenita * MeSH
- lidé MeSH
- multienzymové komplexy chemie nedostatek genetika MeSH
- mutace genetika MeSH
- mutantní proteiny chemie genetika MeSH
- novorozenec MeSH
- sekundární struktura proteinů MeSH
- stabilita enzymů MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- novorozenec MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- adenylsukcinátlyasa MeSH
- multienzymové komplexy MeSH
- mutantní proteiny MeSH
Adenylosuccinate lyase (ADSL) deficiency is neurometabolic disease characterized by accumulation of dephosphorylated enzyme substrates SAICA-riboside (SAICAr) and succinyladenosine (S-Ado) in body fluids of affected individuals. The phenotypic severity differs considerably among patients: neonatal fatal, severe childhood, and moderate phenotypic forms correlating with different values for the ratio between S-Ado and SAICAr concentrations in cerebrospinal fluid have been distinguished. To reveal the biochemical and structural basis for this phenotypic heterogeneity, we expressed and characterized 19 ADSL mutant proteins identified in 16 patients representing clinically distinct subgroups. Respecting compound heterozygosity and considering the homotetrameric structure of ADSL, we used intersubunit complementation and prepared and characterized genotype-specific heteromeric mutant ADSL complexes. We correlated clinical phenotypes with biochemical properties of the mutant proteins and predicted structural impacts of the mutations. We found that phenotypic severity in ADSL deficiency is correlated with residual enzymatic activity and structural stability of the corresponding mutant ADSL complexes and does not seem to result from genotype-specific disproportional catalytic activities toward one of the enzyme substrates. This suggests that the S-Ado/SAICAr ratio is probably not predictive of phenotype severity; rather, it may be secondary to the degree of the patient's development (i.e., to the age of the patient at the time of sample collection).
Citace poskytuje Crossref.org
Expanding clinical spectrum of PAICS deficiency: Comprehensive analysis of two sibling cases
Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds
Combined Targeted and Untargeted Profiling of HeLa Cells Deficient in Purine De Novo Synthesis
Mass spectrometric analysis of purine de novo biosynthesis intermediates